Madrigal Pharmaceuticals is moving from rapid growth to a self-sustaining business model, with its drug Rezdiffra now covering enterprise costs ahead of important 2027 data. In Q2, net sales rose 71% to $364.3 million, supported by over 50,000 patients using Rezdiffra and high gross margins of 89%, indicating strong fundamentals and low market penetration around 11%. Despite a headline loss, the company’s recurring cash operations are breakeven or slightly positive, and cash reserves have increased, enabling continued investment in commercial activities and pipeline development. The current valuation appears to reflect only the ongoing business, while patent protection, pipeline potential, and expansion opportunities offer significant upside.
Madrigal Pharmaceuticals is the subject of this update, with Pluang's Health sector data as of Oct 21, 2026 02:12 WIB providing market context. Of 150 priced Health-sector US stocks tradable on Pluang, 133 rose and 16 fell today. Notable movers include SLS at USD 11.95 with a 13.92% increase and balanced Pluang order activity, RLAY at USD 18.62 up 8.95%, and TDOC at USD 6.22 rising 8.55% despite predominantly sell orders. The most notable figure is SLS's 13.92% gain.
Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Collector Crypt, a Solana-based marketplace that tokenizes physical trading cards, has surpassed both Hyperliquid and Papertrade in 24-hour revenue, reaching over $532,550. This signals a shift in the crypto market towards tokenized collectibles rath...
